Patient groups blast "arrogant" G-BA:
This article was originally published in Clinica
Incensed by the continued refusal of the German joint federal committee (G-BA) to fulfill health minister Ulla Schmidt's request for enteral nutrition to be reimbursed, patient groups have branded the G-BA "arrogant" and "bureaucratic". The committee has reacted to Ms Schmidt's third reminder with a 40-page "intransparent bureaucratic monster" of a draft decision, which it is apparently prepared to enact. Tens of thousands of patients require enteral nutrition in Germany, say the Right to Food and Life and the SHG parents' initiative, whose spokespersons, Ekkehard Bahlo and Monika Boeckmann, have jointly urged the minister to hold firm and insist that the current law, and provision for reimbursement, remain in place.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.